XNCR
Xencor, Inc.
NASDAQ · USHealthcareBiotechnology
$18.81+7.67%
Price as of Jul 20, 2026
XNCR valuation
Xencor, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 10.81x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.70x
- Price / sales
- 14.32x
- Price / cash flow
- -7.48x
Enterprise value
- Enterprise value
- $1.1B
- EV / sales
- 11.55x
- EV / EBITDA
- -8.54x
- EV / EBIT
- -5.30x
- Market cap
- $1.4B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.